Anew Medical Secures US Patent for Gene Therapy for Neurodegenerative, Age-Related Disorders
Anew Medical (WENA) said Thursday it secured a US patent covering an RNA splice variant of human Klotho gene "s-KL" for the treatment of cognitive and neurodegenerative diseases.
The patent follows similar patents issued in Europe, China and other Asian markets, according to the company.
The intellectual property portfolio provides the company with rights to develop and commercialize new therapies for neurodegenerative diseases, including Alzheimer's, amyotrophic lateral sclerosis, Parkinson's, and other age-related disorders, the company said.
Price: 0.9505, Change: -0.05, Percent Change: -4.95
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。